SCHEMBL3663497

SCHEMBL3663497

COc1ccc(-c2c(-c3ccccc3)oc(C)c2C(=O)Nc2cccc(O)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
ADORA3 P0DMS8 2/20 0.50
MAOB P27338 2/20 0.49
ADORA1 P30542 1/20 0.49
MAPT P10636 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TP53 P04637 2/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
STAT3 P40763 1/20 0.48
STAT1 P42224 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3663494 0.90 ADORA3 (0.50) NPC1RAB9AADORA3MAPTALDH1A1
SCHEMBL6524914 0.85 KMT2A (0.50) NPC1RAB9AADORA3MAPTALDH1A1
SCHEMBL12791164 0.85 HTT (0.55) NPC1ADORA3MAPTALDH1A1HPGD
SCHEMBL12791098 0.85 ALDH1A1 (0.52) NPC1ADORA3MAPTALDH1A1HPGD
SCHEMBL6517154 0.79 L3MBTL1 (0.57) NPC1MAPTALDH1A1HPGDMEN1
SCHEMBL3668412 0.79 ALDH1A1 (0.55) NPC1RAB9AMAPTALDH1A1HPGD
SCHEMBL12791142 0.73 SMN1; SMN2 (0.48) NPC1RAB9AMAPTALDH1A1HPGD
SCHEMBL12791258 0.73 SMN1; SMN2 (0.48) NPC1RAB9AMAPTALDH1A1HPGD
SCHEMBL3665405 0.72 SMN1; SMN2 (0.47) NPC1RAB9AMAPTALDH1A1HPGD
SCHEMBL3663483 0.72 SMN1; SMN2 (0.47) NPC1RAB9AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240461-A1 SUBSTITUTED FURANS AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-10-20 EP disclosed
WO-2009097991-A1 SUBSTITUTED FURANS AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-08-13 WO disclosed